Staff Publications: August-September 2018

  1. Ackroyd SA, Brown J, Houck K, et al. A Preoperative Risk Score to Predict Red Blood Cell Transfusion in Patients Undergoing Hysterectomy for Ovarian Cancer. Am J Obstet Gynecol. 2018. PMID: 30240655.
  2. Bella R, Kaminski R, Mancuso P, et al. Removal of HIV DNA by CRISPR from Patient Blood Engrafts in Humanized Mice. Mol Ther Nucleic Acids. 2018;12:275-282. PMID: 30195766. PMC6011019.
  3. Berry K, Elder D, Kroger L. The Evolving Role of the Medical Radiation Safety Officer. Health Phys. 2018;115(5):628-636. PMID: 30260854.
  4. Bevelacqua JJ, Mortazavi SMJ. Commentary: Immune System Dysregulation During Spaceflight: Potential Countermeasures for Deep Space Exploration Missions. Front Immunol. 2018;9:2024. PMID: 30233600. PMC6131484.
  5. Bodor JN, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. J Oncol Pract. 2018;14(9):529-535. PMID: 30205771.
  6. Borgmann H, Cooperberg M, Murphy D, et al. Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social Media. Eur Urol. 2018. PMID: 30177286.
  7. Boumber Y. Tumor Mutational Burden (TMB) as a Biomarker of Response to Immunotherapy in Small Cell Lung Cancer. J Thorac Dis. 2018;10(8):4689-4693. PMID: 30233840. PMC6129910.
  8. Bryan MS, Argos M, Andrulis IL, et al. Germline Variation and Breast Cancer Incidence: A Gene-Based Association Study and Whole-Genome Prediction of Early-Onset Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 2018;27(9):1057-1064. PMID: 29898891 PMCID: PMC6125194.
  9. Bukavina L, Tilburt JC, Konety B, et al. Perceptions of Prostate MRI and Fusion Biopsy of Radiation Oncologists and Urologists for Patients Diagnosed with Prostate Cancer: Results from a National Survey. Eur Urol Focus. 2018. PMID: 30219709.
  10. Burton LJ, Hawsawi O, Loyd Q, et al. Association of Epithelial Mesenchymal Transition with Prostate and Breast Health Disparities. PLoS One. 2018;13(9):e0203855. PMID: 30199553. PMC6130866.
  11. Cheung JY, Gordon J, Wang J, et al. Mitochondrial Dysfunction in Human Immunodeficiency Virus-1 Transgenic Mouse Cardiac Myocytes. J Cell Physiol. 2018. PMID: 30256393.
  12. Doss M. Are We Approaching the End of the Lnt Model Era? J Nucl Med. 2018. PMID: 30262515.
  13. Doss M. Pediatric Computed Tomography Scans and Cancer Risk. JAMA Pediatr. 2018. PMID: 30193290.
  14. DuBay DA, Ivankova NV, Herby I, et al. A Quantitative Appraisal of African Americans’ Decisions to Become Registered Organ Donors at the Driver’s License Office. Clin Transplant. 2018:e13402. PMID: 30179271.
  15. Fakhry C, Nguyen-Tan PF, Lambert L, et al. In Regard to Bossi Et Al. Int J Radiat Oncol Biol Phys. 2018;102(3):669-670. PMID: 30238902. Letter.
  16. Flaig TW, Spiess PE, Agarwal N, et al. Nccn Guidelines Insights: Bladder Cancer, Version 5.2018. J Natl Compr Canc Netw. 2018;16(9):1041-1053. PMID: 30181416.
  17. Fragoso MF, Romualdo GR, Vanderveer LA, et al. Lyophilized Acai Pulp (Euterpe Oleracea Mart) Attenuates Colitis-Associated Colon Carcinogenesis While Its Main Anthocyanin Has the Potential to Affect the Motility of Colon Cancer Cells. Food Chem Toxicol. 2018;121:237-245. PMID: 30194994.
  18. Ghadimi-Moghadam A, Mortazavi SMJ, Hosseini-Moghadam A, et al. Does Exposure to Static Magnetic Fields Generated by Magnetic Resonance Imaging Scanners Raise Safety Problems for Personnel? Journal of Biomedical Physics and Engineering. 2018;8(3):333-336.
  19. Goel N, D’Souza JW, Ruth KJ, et al. The Utility of Preoperative Vascular Grading in Patients Undergoing Surgery First for Pancreatic Cancer: Does Radiologic Arterial or Venous Involvement Predict Pathologic Margin Status? J Oncol. 2018;2018:7675262. PMID: 30186324. PMC6110012.
  20. Hall MJ, Morris AM, Sun W. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance. Am Soc Clin Oncol Educ Book. 2018(38):220-230. PMID: 30231337.
  21. Handorf EA, Heckman CJ, Darlow S, Slifker M, Ritterband L. A Hierarchical Clustering Approach to Identify Repeated Enrollments in Web Survey Data. Plos One. 2018;13(9):e0204394. PMID: 30252908.
  22. Hedges SB, Tao Q, Walker M, Kumar S. Accurate Timetrees Require Accurate Calibrations. Proc Natl Acad Sci U S A. 2018. PMID: 30266795. Letter.
  23. Jin X, Daher SS, Lee M, Buttaro B, Andrade RB. Ribosome-Templated Azide-Alkyne Cycloadditions Using Resistant Bacteria as Reaction Vessels: In Cellulo Click Chemistry. ACS Med Chem Lett. 2018;9(9):907-911. PMID: 30258539. PMC6142060.
  24. Johnson M, Pennell NA, Borghaei H. “My Patient Was Diagnosed with Nontargetable Advanced Non-Small Cell Lung Cancer. What Now?” Diagnosis and Initial Treatment Options for Newly Diagnosed Patients with Advanced Nsclc. Am Soc Clin Oncol Educ Book. 2018(38):696-707. PMID: 30231362.
  25. Kishan AU, Wang X, Seiferheld W, et al. Association of Gleason Grade with Androgen Deprivation Therapy Duration and Survival Outcomes: A Systematic Review and Patient-Level Meta-Analysis. JAMA Oncology. 2018.
  26. Kondrashova O, Topp M, Nesic K, et al. Methylation of All BRCA1 Copies Predicts Response to the PARP Inhibitor Rucaparib in Ovarian Carcinoma. Nat Commun. 2018;9(1):3970. PMID: 30266954. PMC6162272.
  27. Lee M, Hu D, Bunney G, et al. Health Behavior Practice among Understudied Chinese and Filipino Americans with Cardiometabolic Diseases. Prev Med Rep. 2018;11:240-246. PMID: 30210996. PMC6129966.
  28. Mani S, Ghosh J, Lan Y, et al. Epigenetic Changes in Reterm Birth Placenta Suggest a Role for Adamts Genes in Spontaneous Preterm Birth. Hum Mol Genet. 2018. PMID: 30239759.
  29. Manne SL, Kashy DA, Kissane DW, Ozga M, Virtue SM, Heckman CJ. The Course and Predictors of Perceived Unsupportive Responses by Family and Friends among Women Newly Diagnosed with Gynecological Cancers. Transl Behav Med. 2018. PMID: 30189025.
  30. Martin JM, Goldstein LJ. Profile of Abemaciclib and Its Potential in the Treatment of Breast Cancer. Onco Targets Ther. 2018;11:5253-5259. PMID: 30214230. PMC6120573.
  31. Mitchell TC, Hamid O, Smith DC, et al. Epacadostat Plus Pembrolizumab in Patients with Advanced Solid Tumors: Phase I Results from a Multicenter, Open-Label Phase I/Ii Trial (Echo-202/Keynote-037). J Clin Oncol. 2018:Jco2018789602. PMID: 30265610.
  32. Moten AS, Zhao H, Wu H, Farma JM. Malignant Granular Cell Tumor: Clinical Features and Long-Term Survival. J Surg Oncol. 2018. PMID: 30196562.
  33. Nacson J, Krais JJ, Bernhardy AJ, et al. Brca1 Mutation-Specific Responses to 53bp1 Loss-Induced Homologous Recombination and Parp Inhibitor Resistance. Cell Rep. 2018;24(13):3513-3527.e3517. PMID: 30257212.
  34. Nicholas Bodor J, Kasireddy V, Borghaei H. First-Line Therapies for Metastatic Lung Adenocarcinoma without a Driver Mutation. Journal of Oncology Practice. 2018;14(9):529-535.
  35. Ogba N, Arwood NM, Bartlett NL, et al. Chimeric Antigen Receptor T-Cell Therapy. J Natl Compr Canc Netw. 2018;16(9):1092-1106. PMID: 30181421.
  36. Pakyz AL, Kohinke R, Opper P, Hohmann SF, Jones RM, Nadpara P. High-Risk Medication Use for Clostridium Difficile Infection among Hospitalized Patients with Cancer. Am J Infect Control. 2018. PMID: 30220616.
  37. Paliwal Y, Gendron TL, Jones RM, Moczygemba L, Nadpara PA, Slattum PW. A Qualitative Study to Understand over-the-Counter Medication Use and Decision-Making among Residents of Senior-Living Communities. Res Social Adm Pharm. 2018. PMID: 30253975.
  38. Radich JP, Deininger M, Abboud CN, et al. Chronic Myeloid Leukemia, Version 1.2019 Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2018;16(9):1108-1135. PMID: 30181422.
  39. Riddle DL, Slover JD, Ang DC, et al. Opioid Use Prior to Knee Arthroplasty in Patients Who Catastrophize About Their Pain: Preoperative Data from a Multisite Randomized Clinical Trial. J Pain Res. 2018;11:1549-1557. PMID: 30174454. PMC6109658.
  40. Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial Nephrectomy Is Not Associated with an Overall Survival Advantage over Radical Nephrectomy in Elderly Patients with Stage I and Ii Renal Masses: An Analysis of the National Cancer Database. Cancer. 2018. PMID: 30207380.
  41. Roberts ME, Aynardi JT, Chu CS. Uterine Leiomyosarcoma: A Review of the Literature and Update on Management Options. Gynecol Oncol. 2018. PMID: 30244960.
  42. Rudolph MJ, Vance DJ, Kelow S, et al. Contribution of an Unusual Cdr2 Element of a Single Domain Antibody in Ricin Toxin Binding Affinity and Neutralizing Activity. Protein Eng Des Sel. 2018. PMID: 30265352.
  43. Singh T, Lee EH, Hartman TR, Ruiz-Whalen DM, O’Reilly AM. Opposing Action of Hedgehog and Insulin Signaling Balances Proliferation and Autophagy to Determine Follicle Stem Cell Lifespan. Dev Cell. 2018;46(6):720-734.e726. PMID: 30197240. PMC6159899. NIHMS1504158.
  44. Thenuwara AC, Cerkez EB, Shumlas SL, et al. Nickel Confined in the Interlayer Region of Birnessite: An Active Electrocatalyst for Water Oxidation. Angew Chem Int Ed Engl. 2016;55(35):10381-10385. PMID: 27151204.
  45. Tong CMC, Lucas J, Shah A, Foote C, Simhan J. Author Reply to Editorial Comment on “Novel Multimodal Analgesia Protocol Significantly Decreases Opioid Requirements in Inflatable Penile Prosthesis Patients”. Journal of Sexual Medicine. 2018;15(9):1364-1365. PMID: 30224023.
  46. Ward WH, Fluke LM, McEvoy CS, Fitch JL, Ricca RL. An Examination of Military General Surgeon Comfort with Complex Hepatopancreatobiliary Procedures. American Surgeon. 2018;84(8):E343-E345. PMID: 30185350.
  47. Wheeler DC, Jones RM, Schootman M, Nelson EJ. Explaining Variation in Elevated Blood Lead Levels among Children in Minnesota Using Neighborhood Socioeconomic Variables. Science of the Total Environment. 2019;650:970-977.
  48. Winkfield KM, Phillips JK, Joffe S, Halpern MT, Wollins DS, Moy B. Addressing Financial Barriers to Patient Participation in Clinical Trials: Asco Policy Statement. J Clin Oncol. 2018:Jco1801132. PMID: 30212297.
  49. Wu S, Luo Y, Viswanathan U, et al. Cpams Induce Assembly of Hbv Capsids with Altered Electrophoresis Mobility: Implications for Mechanism of Inhibiting Pgrna Packaging. Antiviral Res. 2018;159:1-12. PMID: 30201396.
  50. Zhang Y, Arango G, Li F, et al. Comprehensive Off-Target Analysis of Dcas9-Sam-Mediated Hiv Reactivation Via Long Noncoding Rna and Mrna Profiling. BMC Med Genomics. 2018;11(1):78. PMID: 30200981. PMC6131778.
  51. Zuniga SA, Lango MN. Effect of Rural and Urban Geography on Larynx Cancer Incidence and Survival. Laryngoscope. 2018;128(8):1874-1880. PMID: 29238975.

Is this Journal Legitimate?

Every now and then someone forwards an email from a publisher inviting him or her or them to review submissions, submit an article, or be on the editorial board of a journal. I start reading and three things jump out at me:

  • Reputable journals and conferences don’t email you out of the blue.
  • This email is not very well written.
  • Considering that the representative from this journal is contacting this clinician/researcher for the first time, it’s very informal.

There have been unscrupulous publishers for as long as there have been publishers. They are in the minority but their numbers are growing, and they are becoming more sophisticated. The following are some of the things we look for:

The Journal

  • Does the journal have an valid ISSN?
    • Why does this matter? When a publisher applies for an ISSN, they must provide information and supporting documentation to the ISSN International Centre including: title, frequency, publisher’s name, and medium along with copies of the title page, cover page, editorial page, PDF or JPG of the jacket (if the publication is on CD-ROM), and the URL if the journal is online. Publishers can apply for an ISSN in advance of publication. If the journal does not have an ISSN, be wary of the publisher.
  • Is the current issue available online?
    • Are any back issues available online? If so, does the content look credible? Do you recognize any of the authors?
  • Are their copyright policies, open access policies (where applicable), and peer-review policies and processes explained clearly?
    • More and more predatory journals are putting these policies online. Make sure they make sense and weigh them carefully against other factors, like lacking an ISSN.
  • If the journal boasts an Impact Factor or an Eigenfactor, can it be verified through Journal Citation Reports or, respectively?
    • The Talbot Library subscribes to Journal Citation Reports. The Eigenfactor can be verified at
  • If the journal claims to be indexed in a particular database (PubMed, Web of Science, SCOPUS, EMBASE) search any or all of those databases to verify the claim.
    • Unscrupulous publishers have been known to create false indexes and claim their journal is indexed there. Something else to keep in mind is every once in a while an article from a predatory journal does make its way into a database.

The Publisher

  • Does the publisher provide full, verifiable contact information including the street address, a working email address, and a working telephone number either in the email message or on the Web site?
    • If you are unsure of the publisher’s veracity, you are well within your rights to phone or email. I prefer phoning, myself. Last time I phoned a questionable publisher, I was bounced into a random, numbered voicemail.
  • If the journal charges publication fees, are they stated up-front and explained clearly?
  • Does the publisher have a Web site? Are the pages within that site stable?
  • On the Web site, check for language use, grammatical errors, and typographical errors. Is the language stilted? Overly formal? Strangely inappropriate?
    • I once ran across a publisher who took great pains to state that they were an American publishing organization, as opposed to an American publisher. Yet they used the British spelling of gynecological.
    • This same publisher described a nursing journal as follows, “Nursing, the word itself reflects a “care” in it and can be treated as the most divine and dedicated professional science that helps patients in the severely ill circumstances from the time of birth till death.”
  • Is the publisher listed in Ulrich’s or  SHERPA/Romeo?
    • Ulrich’s and SHERPA/Romeo will tell you where a publisher is headquartered, where a journal is indexed, how often new issues are released (frequency), and more. SHERPA/Romeo is available free online but ask one of us in the library to search Ulrich’s.

What can I do?

  • Be very wary of unsolicited contact from a publisher with whom you are not familiar.
  • Don’t agree to review submissions, submit articles, or join an editorial board of a journal you do not recognize.
  • Check any claims made by the publisher, be they impact factor, member of an editorial board, or incluion in an index or database like Web of Science or PubMed.
  • Keep your online presence current and accurate.
    • Keeping your professional information up to date makes it easier for others to do the due diligence when they are researching a suspect journal.
  • Have you been fooled by a predatory publisher, tell your colleagues.
  • When in doubt about a journal, publisher, or conference, talk to a librarian.
    • Librarians are trained to find and evaluate information. If you have doubts come talk to us, we can look into the publisher for you.

Laboratory Investigation goes Open Access

“Laboratory Investigation now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately.” For more information about their Open Access Hybrid Model, see their Frequently Asked Questions page.